CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.52
0.65%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.53
Open* 1.5
1-Year Change* -86.34%
Day's Range* 1.48 - 1.57
52 wk Range N/A
Average Volume (10 days) N/A
Average Volume (3 months) N/A
Market Cap N/A
P/E Ratio N/A
Shares Outstanding N/A
Revenue N/A
EPS N/A
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 1.53 0.11 7.75% 1.42 1.64 1.41
Apr 18, 2024 1.44 0.10 7.46% 1.34 1.48 1.27
Apr 17, 2024 1.37 -0.09 -6.16% 1.46 1.49 1.23
Apr 16, 2024 1.37 -0.51 -27.13% 1.88 1.98 1.34
Apr 15, 2024 2.81 -0.30 -9.65% 3.11 3.17 2.79
Apr 12, 2024 3.14 -0.12 -3.68% 3.26 3.30 3.11
Apr 11, 2024 3.34 -0.05 -1.47% 3.39 3.43 3.25
Apr 10, 2024 3.31 -0.06 -1.78% 3.37 3.47 3.23
Apr 9, 2024 3.58 0.17 4.99% 3.41 3.67 3.39
Apr 8, 2024 3.43 -0.07 -2.00% 3.50 3.55 3.36
Apr 5, 2024 3.32 0.11 3.43% 3.21 3.40 3.20
Apr 4, 2024 3.30 -0.13 -3.79% 3.43 3.61 3.27
Apr 3, 2024 3.34 0.06 1.83% 3.28 3.49 3.19
Apr 2, 2024 3.38 -0.17 -4.79% 3.55 3.55 3.35
Apr 1, 2024 3.62 -0.16 -4.23% 3.78 3.81 3.56
Mar 28, 2024 3.73 -0.03 -0.80% 3.76 3.86 3.66
Mar 27, 2024 3.69 0.11 3.07% 3.58 3.79 3.52
Mar 26, 2024 3.49 -0.12 -3.32% 3.61 3.63 3.43
Mar 25, 2024 3.58 -0.16 -4.28% 3.74 3.76 3.55
Mar 22, 2024 3.65 -0.13 -3.44% 3.78 3.81 3.64

Pacific Biosciences Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 128.304 130.513 78.893 90.891 78.626
Revenue 128.304 130.513 78.893 90.891 78.626
Cost of Revenue, Total 75.564 71.653 46.327 56.315 53.53
Gross Profit 52.74 58.86 32.566 34.576 25.096
Total Operating Expense 435.5 392.948 51.278 173.436 179.613
Selling/General/Admin. Expenses, Total 160.854 124.124 72.799 75.491 63.489
Research & Development 193 112.899 64.152 59.63 62.594
Unusual Expense (Income) 3.705 83.129 -132 -18
Operating Income -307.196 -262.435 27.615 -82.545 -100.987
Interest Income (Expense), Net Non-Operating -14.69 -12.53 -0.267 -2.595 -2.423
Other, Net 7.638 0.093 2.055 1.006 0.848
Net Income Before Taxes -314.248 -274.872 29.403 -84.134 -102.562
Net Income After Taxes -314.248 -181.223 29.403 -84.134 -102.562
Net Income Before Extra. Items -314.248 -181.223 29.403 -84.134 -102.562
Total Extraordinary Items
Net Income -314.248 -181.223 29.403 -84.134 -102.562
Income Available to Common Excl. Extra. Items -314.248 -181.223 29.403 -84.134 -102.562
Income Available to Common Incl. Extra. Items -314.248 -181.223 29.403 -84.134 -102.562
Diluted Net Income -314.248 -181.223 29.403 -84.134 -102.562
Diluted Weighted Average Shares 224.55 204.136 174.97 152.527 135.094
Diluted EPS Excluding Extraordinary Items -1.39946 -0.88776 0.16805 -0.5516 -0.75919
Diluted Normalized EPS -1.38296 -0.62306 -0.58637 -0.66961 -0.75919
Other Operating Expenses, Total 2.377 1.143
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 47.573 38.9 27.353 32.311 35.467
Revenue 47.573 38.9 27.353 32.311 35.467
Cost of Revenue, Total 32.027 29.139 18.508 18.764 19.274
Gross Profit 15.546 9.761 8.845 13.547 16.193
Total Operating Expense 122.781 130.152 114.437 106.931 103.436
Selling/General/Admin. Expenses, Total 40.573 39.818 45.003 36.795 39.252
Research & Development 46.173 48.939 42.623 47.092 50.348
Unusual Expense (Income) 2.033 3.705 0 0
Other Operating Expenses, Total 1.975 12.256 4.598 4.28 -5.438
Operating Income -75.208 -91.252 -87.084 -74.62 -67.969
Interest Income (Expense), Net Non-Operating -3.554 -3.63 -3.648 -3.664 -3.681
Other, Net 8.929 6.867 6.348 1.313 0.256
Net Income Before Taxes -69.833 -88.015 -84.384 -76.971 -71.394
Net Income After Taxes -69.833 -88.015 -84.384 -76.971 -71.394
Net Income Before Extra. Items -69.833 -88.015 -84.384 -76.971 -71.394
Net Income -69.833 -88.015 -84.384 -76.971 -71.394
Income Available to Common Excl. Extra. Items -69.833 -88.015 -84.384 -76.971 -71.394
Income Available to Common Incl. Extra. Items -69.833 -88.015 -84.384 -76.971 -71.394
Diluted Net Income -69.833 -88.015 -84.384 -76.971 -71.394
Diluted Weighted Average Shares 250.07 242.032 226.257 225.123 224.499
Diluted EPS Excluding Extraordinary Items -0.27925 -0.36365 -0.37296 -0.34191 -0.31801
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.27112 -0.36365 -0.35658 -0.34191 -0.31801
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 852.074 1101.13 355.587 81.046 131.659
Cash and Short Term Investments 772.318 1044.4 318.814 49.099 102.354
Cash & Equivalents 325.089 460.725 81.611 29.627 18.844
Short Term Investments 447.229 583.675 237.203 19.472 83.51
Total Receivables, Net 18.786 24.241 16.837 15.266 8.595
Accounts Receivable - Trade, Net 18.786 24.241 16.837 15.266 8.595
Total Inventory 50.381 24.599 14.23 13.312 17.878
Prepaid Expenses 10.289 7.394 4.87 3.369 2.832
Other Current Assets, Total 0.3 0.5 0.836
Total Assets 1767.09 2006.97 413.98 147.985 170.275
Property/Plant/Equipment, Total - Net 81.343 79.121 54.85 62.897 34.073
Property/Plant/Equipment, Total - Gross 146.331 135.407 104.741 107.115 71.18
Accumulated Depreciation, Total -64.988 -56.286 -49.891 -44.218 -37.107
Other Long Term Assets, Total 13.45 5.762 3.543 4.042 4.543
Total Current Liabilities 263.335 71.709 38.502 49.153 26.884
Accounts Payable 12.028 11.002 3.579 8.368 6.736
Accrued Expenses 41.482 43.971 21.682 17.079 12.823
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 208.025 16.736 13.241 7.835 7.325
Total Liabilities 1204.18 1215.98 78.489 93.068 56.214
Total Long Term Debt 897.183 896.067 0 0 14.659
Long Term Debt 897.183 896.067 0 14.659
Other Liabilities, Total 43.664 248.207 39.987 43.915 14.671
Total Equity 562.904 790.987 335.491 54.917 114.061
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.227 0.221 0.192 0.153 0.15
Additional Paid-In Capital 2099.78 2009.94 1372.08 1121 1096.05
Retained Earnings (Accumulated Deficit) -1532.34 -1218.09 -1036.87 -1066.24 -982.106
Other Equity, Total -4.765 -1.087 0.085 0.005 -0.036
Total Liabilities & Shareholders’ Equity 1767.09 2006.97 413.98 147.985 170.275
Total Common Shares Outstanding 226.505 220.978 192.294 153.119 150.244
Current Port. of LT Debt/Capital Leases 1.8 0 15.871
Goodwill, Net 409.974 409.974
Intangibles, Net 410.245 410.979
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 882.297 935.552 981.111 852.074 913.896
Cash and Short Term Investments 767.789 829.862 874.892 772.318 834.34
Cash & Equivalents 385.648 209.287 353.834 325.089 304.433
Short Term Investments 382.141 620.575 521.058 447.229 529.907
Total Receivables, Net 30.486 24.034 29.589 18.786 22.756
Accounts Receivable - Trade, Net 30.486 24.034 29.589 18.786 22.756
Total Inventory 68.256 67.608 61.955 50.381 43.495
Prepaid Expenses 15.466 13.748 14.375 10.289 13.005
Other Current Assets, Total 0.3 0.3 0.3 0.3 0.3
Total Assets 1898.35 1847.63 1896.42 1767.09 1818.95
Property/Plant/Equipment, Total - Net 74.95 76.761 79.08 81.343 80.687
Goodwill, Net 463.843 409.974 409.974 409.974 409.974
Intangibles, Net 461.838 409.779 410.011 410.245 410.294
Other Long Term Assets, Total 15.426 15.565 16.241 13.45 4.098
Total Current Liabilities 183.961 271.409 265.674 263.335 81.649
Accounts Payable 16.106 16.512 17.39 12.028 12.853
Accrued Expenses 44.12 36.253 28.398 41.482 33.498
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 122.835 217.244 217.986 209.825 35.298
Total Liabilities 1134.61 1205.63 1204.3 1204.18 1192.36
Total Long Term Debt 891.996 891.795 896.839 896.683 896.529
Long Term Debt 891.996 891.795 896.839 896.683 896.529
Other Liabilities, Total 58.654 42.428 41.787 44.164 214.18
Total Equity 763.743 641.999 692.117 562.904 626.591
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.258 0.25 0.25 0.227 0.226
Additional Paid-In Capital 2522.38 2334.62 2314.15 2099.78 2080.58
Retained Earnings (Accumulated Deficit) -1757.06 -1690.19 -1620.35 -1532.34 -1447.96
Other Equity, Total -1.84 -2.686 -1.924 -4.765 -6.26
Total Liabilities & Shareholders’ Equity 1898.35 1847.63 1896.42 1767.09 1818.95
Total Common Shares Outstanding 258.374 250.473 249.803 226.505 225.916
Current Port. of LT Debt/Capital Leases 0.9 1.4 1.9
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -314.248 -181.223 29.403 -84.134 -102.562
Cash From Operating Activities -263.211 -111.18 19.503 -78.312 -66.43
Cash From Operating Activities 9.48 7.199 6.428 7.265 7.215
Non-Cash Items 94.616 135.107 -13.569 1.561 23.252
Cash Interest Paid 14.049 6.928 0.491 1.4 1.4
Changes in Working Capital -53.972 21.005 -2.759 -3.004 5.665
Cash From Investing Activities 116.083 -678.531 -219.322 62.047 -38.415
Capital Expenditures -16.929 -5.931 -1.039 -2.836 -1.854
Other Investing Cash Flow Items, Total 133.012 -672.6 -218.283 64.883 -36.561
Cash From Financing Activities 9.622 1169.58 251.839 26.548 107.182
Issuance (Retirement) of Stock, Net 11.23 326.651 233.839 8.548 107.182
Issuance (Retirement) of Debt, Net -1.608 895.175 -16 0 0
Net Change in Cash -137.506 379.87 52.02 10.283 2.337
Financing Cash Flow Items -52.245 34 18
Amortization 0.913 0.381
Deferred Taxes -93.649
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -88.015 -314.248 -229.864 -152.893 -81.499
Cash From Operating Activities -94.691 -263.211 -202.645 -139.592 -79.029
Cash From Operating Activities 2.755 9.48 6.937 4.591 2.268
Amortization 0.234 0.913 0.685 0.456 0.228
Non-Cash Items 33.464 94.616 65.22 40.172 24.353
Changes in Working Capital -43.129 -53.972 -45.623 -31.918 -24.379
Cash From Investing Activities -72.553 116.083 35.68 -18.228 42.053
Capital Expenditures -3.721 -16.929 -11.846 -7.657 -3.638
Other Investing Cash Flow Items, Total -68.832 133.012 47.526 -10.571 45.691
Cash From Financing Activities 195.989 9.622 8.803 5.67 5.215
Financing Cash Flow Items 0 0 0
Issuance (Retirement) of Stock, Net 196.435 11.23 9.983 6.44 5.592
Issuance (Retirement) of Debt, Net -0.446 -1.608 -1.18 -0.77 -0.377
Net Change in Cash 28.745 -137.506 -158.162 -152.15 -31.761
Deferred Taxes 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Pacific Biosciences

Pacific Biosciences
Industry: Advanced Medical Equipment & Technology (NEC)

1305 O'brien Drive
MENLO PARK
CALIFORNIA 94025
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

Gold

2,330.76 Price
-2.580% 1D Chg, %
Long position overnight fee -0.0197%
Short position overnight fee 0.0114%
Overnight fee time 21:00 (UTC)
Spread 0.40

US100

17,204.50 Price
+1.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,213.36 Price
+1.870% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.56 Price
+6.140% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading